En español
NIDA

Menu

HIV or AIDS

Women and Sex/Gender Differences Research Program

NIDA’s Women and Sex/Gender Differences Research Program focuses on gender-specific addiction risk factors and treatment needs.

Antiretroviral Treatment Reduces Spread of HIV Among Injection Drug Users

Expanded use of antiretroviral therapy in British Columbia reduced the spread of HIV among injection drug users and others in the province.

Blending conference translates substance abuse research into practice

Experts will share the latest clinical research with addiction treatment professionals, healthcare providers, policy makers, and others during the April 19th Blending Conference in Atlanta, Georgia.


NIDA Recognizes Developer of a New Business Model for Science

Dr. Redonna K. Chandler of NIDA receives the Institute's 2011 Innovator Award for developing a method that fosters collaboration and data sharing on various studies of HIV in criminal justice populations.

El abuso de drogas y el SIDA

Descripción breve

El abuso y la adicción de las drogas han estado vinculados de modo inextricable al VIH/SIDA desde el comienzo de la epidemia. Al principio de la epidemia las personas usualmente creían que esta conexión se debía sólo al uso de drogas inyectables y al hábito de compartir agujas.

Journal Highlights Global Nexus of Drug Abuse and HIV/AIDS

Reviews a journal supplement that compiles studies on drug-related HIV transmission, with a focus on injection drug use, in 16 different localities across the globe.

Pages

Subscribe to RSS - HIV or AIDS

Attention

Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at

Looking for Treatment?

Use the SAMHSA Treatment Locator or 1-800-662-HELP.

Helpline open during government shutdown